TYP 5.26% 1.8¢ tryptamine therapeutics limited

Guess the smart money must think differently about EX1's claims...

  1. 131 Posts.
    lightbulb Created with Sketch. 19
    Guess the smart money must think differently about EX1's claims to having the leading technology in exosomes with Lonza buying Codiak's exosome manufacturing facility. Lonza has also recently bought Exosomics. So this is the year we LEAP. Yep, sure.
 
watchlist Created with Sketch. Add TYP (ASX) to my watchlist
(20min delay)
Last
1.8¢
Change
-0.001(5.26%)
Mkt cap ! $19.60M
Open High Low Value Volume
1.9¢ 1.9¢ 1.8¢ $14.08K 743.8K

Buyers (Bids)

No. Vol. Price($)
1 500000 1.9¢
 

Sellers (Offers)

Price($) Vol. No.
2.0¢ 76164 1
View Market Depth
Last trade - 15.34pm 06/09/2024 (20 minute delay) ?
TYP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.